5:48 PM
 | 
Oct 22, 2013
 |  BC Extra  |  Company News

EC approves Gentium's defibrotide

The European Commission approved an MAA from Gentium S.p.A. (NASDAQ:GENT) for Defitelio defibrotide to treat severe hepatic...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >